Nucleome Therapeutics nominates first preclinical development candidate First-in-class monoclonal antibody agonist programme for inflammation resolution with broad applicability across major chronic ...

Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseasesCAMBRIDGE, England--(BUSINESS ...

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

A new study finds blue zones longevity research holds up after strict verification of age records used to confirm exceptional ...

DNA analysis of cultural artifacts shows diverse biological profiles, but contamination and mixed signals complicate ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

Ultragenyx Pharmaceutical (RARE) remains a Sell after its Phase 3 OI program failed to meet primary fracture reduction ...

AEye, Inc. , a global leader in software-defined lidar solutions and the manufacturer of the Apollo lidar sensor, continues to set new standards in lidar detection with today's announcement of ...

When the three-million-year-old bones of Lucy were unearthed in an Ethiopian valley in 1974, paleoanthropologists anointed ...

PlusAI, a leader in AI software for autonomous trucks, today announced the appointment of two new Board members, David C. Peterschmidt and Harry J. Harczak, Jr., seasoned leaders with decades of ...

SELLAS is currently evaluating Galinpepimut-S (GPS) as a potential maintenance therapy in patients with Acute Myeloid ...

Reality sometimes feels stranger than fiction. Throughout history, certain events have unfolded in ways that defy logic and ...